Alignment Healthcare (NASDAQ:ALHC – Get Free Report) and Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.
Insider & Institutional Ownership
86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 5.2% of Alignment Healthcare shares are owned by company insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares Alignment Healthcare and Intelligent Bio Solutions’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alignment Healthcare | 0.47% | 11.50% | 1.79% |
| Intelligent Bio Solutions | -296.73% | -176.09% | -89.71% |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alignment Healthcare | $4.26 billion | 1.13 | -$720,000.00 | $0.09 | 258.44 |
| Intelligent Bio Solutions | $3.05 million | 1.74 | -$10.57 million | ($12.22) | -0.18 |
Alignment Healthcare has higher revenue and earnings than Intelligent Bio Solutions. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Alignment Healthcare and Intelligent Bio Solutions, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alignment Healthcare | 0 | 3 | 6 | 1 | 2.80 |
| Intelligent Bio Solutions | 1 | 0 | 0 | 0 | 1.00 |
Alignment Healthcare presently has a consensus target price of $24.30, indicating a potential upside of 4.47%. Given Alignment Healthcare’s stronger consensus rating and higher possible upside, analysts plainly believe Alignment Healthcare is more favorable than Intelligent Bio Solutions.
Risk & Volatility
Alignment Healthcare has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.21, meaning that its share price is 321% more volatile than the S&P 500.
Summary
Alignment Healthcare beats Intelligent Bio Solutions on 13 of the 15 factors compared between the two stocks.
About Alignment Healthcare
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
About Intelligent Bio Solutions
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
